Detection of preclinically latent hyperperfusion due to stroke-like episodes by arterial spin-labeling perfusion MRI
Masamichi Ikawa1, Makoto Yoneda, Tomoko Muramatsu
1Second Department of Internal Medicine, Faculty of Medical Sciences, University of Fukui, 23-3 Shimoaiduki, Matsuoka, Eiheiji-cho, Fukui 910-1193, Japan.
Abstract:
In stroke-like episodes (SEs) of patients with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS), the detection of preclinically latent lesions is a challenge. We report regional cerebral hyperperfusion observed on arterial spin labeling (ASL) perfusion magnetic resonance imaging (MRI) in the preclinical phase more than 3 months before the clinical onset of SEs in 3 MELAS patients. These hyperperfused areas were not detected by conventional MRI in the preclinical phase and developed into acute lesions at the clinical onset of SEs, suggesting that ASL imaging has the potential for predicting the emergence of SEs.
Insights
Arterial spin labeling (ASL) MRI detected preclinical cerebral hyperperfusion in Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, and Stroke-like episodes (MELAS) patients. This finding may help predict impending stroke-like episodes (SEs) months before they occur.
Area of Science:
- Neurology
- Radiology
- Mitochondrial Diseases
Background:
- Detecting preclinical lesions in MELAS patients is challenging.
- Stroke-like episodes (SEs) are a significant complication of MELAS.
Purpose of the Study:
- To investigate the utility of arterial spin labeling (ASL) perfusion MRI in identifying preclinical lesions in MELAS patients.
- To assess ASL's potential for predicting the onset of SEs.
Main Methods:
- Utilized ASL perfusion magnetic resonance imaging (MRI) in three MELAS patients.
- Compared ASL findings with conventional MRI in the preclinical phase of SEs.
Main Results:
- Regional cerebral hyperperfusion was observed on ASL MRI more than 3 months before clinical SE onset in all three patients.
- These hyperperfused areas were not detectable by conventional MRI during the preclinical phase.
- The preclinical hyperperfused areas evolved into acute lesions at the clinical onset of SEs.
Conclusions:
- ASL perfusion MRI can detect preclinical cerebral hyperperfusion in MELAS patients.
- ASL imaging shows potential for predicting the emergence of SEs in MELAS.
- Early detection of preclinical lesions may enable timely intervention for MELAS patients.


